Oncolytic Adenovirus in Cancer Immunotherapy
Tumor-selective replicating “oncolytic” viruses are novel and promising tools for immunotherapy of cancer. However, despite their first success in clinical trials, previous experience suggests that currently used oncolytic virus monotherapies will not be effective enough to achieve complete tumor re...
Main Authors: | Malin Peter, Florian Kühnel |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/11/3354 |
Similar Items
-
Oncolytic Adenovirus: Prospects for Cancer Immunotherapy
by: Yaqi Zhao, et al.
Published: (2021-07-01) -
Oncolytic viruses for cancer immunotherapy
by: Otto Hemminki, et al.
Published: (2020-06-01) -
Oncolytic Adenoviruses in Cancer Treatment
by: Ramon Alemany
Published: (2014-02-01) -
Oncolytic Adenoviruses for Cancer Therapy
by: Lorella Tripodi, et al.
Published: (2021-03-01) -
Combining Oncolytic Adenovirus with Radiation—A Paradigm for the Future of Radiosensitization
by: Sean M. O’Cathail, et al.
Published: (2017-07-01)